DOCETAXEL INJECTION USP
DOCETAXEL INJECTION USP
Approved
DIN Number
02361957
Drug Class
Human
Market Date
Mar 1, 2011
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02361957
AIG Number0127884002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD02 DOCETAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DOCETAXELActive
Strength: 10 MG / ML
Monograph: DOCETAXEL